Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 4 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
combat cdi consortium[Corporate Author]
(3 results)?
Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Clin Microbiol Infect. 2023 May;29(5):651.e1-651.e8. doi: 10.1016/j.cmi.2022.12.019. Epub 2022 Dec 29.
Clin Microbiol Infect. 2023.
PMID: 36586512
Free article.
A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.
Viprey VF, Davis GL, Benson AD, Ewin D, Spittal W, Vernon JJ, Rupnik M, Banz A, Allantaz F, Cleuziat P; COMBACTE-CDI National Coordinators; Wilcox MH, Davies KA; COMBACTE-CDI consortium; Members of the COMBACTE-CDI National coordinators.
Viprey VF, et al.
Euro Surveill. 2022 Jun;27(26):2100704. doi: 10.2807/1560-7917.ES.2022.27.26.2100704.
Euro Surveill. 2022.
PMID: 35775426
Free PMC article.
Item in Clipboard
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Viprey VF, Granata G, Vendrik KEW, Davis GL, Petrosillo N, Kuijper EJ, Vilken T, Lammens C, Schotsman JJ, Benson AD, Cataldo MA, van der Kooi TII, Wilcox MH, Davies KA; COMBACTE-CDI consortium.
Viprey VF, et al.
J Hosp Infect. 2023 Jan;131:213-220. doi: 10.1016/j.jhin.2022.11.011. Epub 2022 Dec 1.
J Hosp Infect. 2023.
PMID: 36462673
Free article.
Item in Clipboard
Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model.
Agnew E, Davies KA, Viprey VF, Evans S, Davis GL, Hope R, Wilcox MH, Wingen-Heimann SM, Robotham JV; COMBACTE-CDI consortium.
Agnew E, et al.
Clin Microbiol Infect. 2023 Jun;29(6):796.e1-796.e6. doi: 10.1016/j.cmi.2023.02.004. Epub 2023 Feb 10.
Clin Microbiol Infect. 2023.
PMID: 36773769
Free article.
Item in Clipboard
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
Boekhoud IM, Sidorov I, Nooij S, Harmanus C, Bos-Sanders IMJG, Viprey V, Spittal W, Clark E, Davies K, Freeman J, Kuijper EJ, Smits WK; COMBACTE-CDI Consortium.
Boekhoud IM, et al.
J Antimicrob Chemother. 2021 Jun 18;76(7):1731-1740. doi: 10.1093/jac/dkab097.
J Antimicrob Chemother. 2021.
PMID: 33876817
Free PMC article.
Item in Clipboard
Clostridioides difficile positivity rate and PCR ribotype distribution on retail potatoes in 12 European countries, January to June 2018.
Tkalec V, Viprey V, Davis G, Janezic S, Sente B, Devos N, Wilcox M, Davies K, Rupnik M; COMBACTE-CDI consortium.
Tkalec V, et al.
Euro Surveill. 2022 Apr;27(15):2100417. doi: 10.2807/1560-7917.ES.2022.27.15.2100417.
Euro Surveill. 2022.
PMID: 35426363
Free PMC article.
Item in Clipboard
Cite
Cite